Accès ouvert déclaré 2026 preprint

Adonertinib (FHND9041) versus Afatinib as First-line Treatment for Advanced Non-small-cell Lung Cancer with EGFR Sensitive Mutation (FHND9041-Ⅲ-01): A Multi-centre, Open-label, Randomised Phase 3 Trial

Yuankai Shi, Puyuan Xing, Guowu Wu, Hongbo Wu, Xuhong Mi, Renping Wan, C L Zhang, Yan Wang, Runxiang Yang, Hongyun Zhao, Chengling Zhao, Li Jia, Jianing Qin, Pei Shi, Li Geng, Jinghua Xiao, Xin Hu, Xiangan Lin, Shoujun Guo, J Meng, Yufa Zhou, Yi Qing, Xiaofen Wang, Jinxun Wu, Ning Xu, Yun Wu, J Y Lin, Jiangtao Sun, Qibin Song, Yinyin Li, Ling Lai, Junfei Zhu, Chaoying Liu, Zhenghong Xiao, Na Li, L Y Yang, Hailin Xiong, Ye Min, Xinfu Liu, Hongda Lu, Hongcheng Wu, Junyan Yu, Ruoyu Wang, Fuliang Zhang, Shujuan Sun, Juanwen Lian, Guoqing Yin, Xinpeng Han, Meiling Wen, Youxin Ji, Zhongling Xu, Yahuan Guo, Li Zeng, Guanghua Zhong, Jianwen Luo, Zili Meng, Qiang Lin, Lizhe Sun, Minghong Shang, Yanwei Huang, Dechuang Yuan, Yongqiang Zhu

0Citations signalées, ce qui n’est pas une note de qualité
74Institutions déclarées
3Pays d’affiliation déclarés

Rattachement africain : au, us, cn. Niveau de preuve : code pays fourni par la source.

Résumé indisponible. Les résultats de l’étude ne doivent pas être déduits de son seul titre.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Adonertinib (FHND9041) versus Afatinib as First-line Treatment for Advanced Non-small-cell Lung Cancer with EGFR Sensitive Mutation (FHND9041-Ⅲ-01): A Multi-centre, Open-label, Randomised Phase 3 Trial
Date Crossref
03/07/2026
Éditeur
Springer Science and Business Media LLC
Type
posted-content

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Thales (Australia)National Cancer CenterMeizhou City People's HospitalNingbo Medical Center Lihuili HospitalHenan Cancer HospitalAnhui Medical UniversityAnhui Provincial HospitalShantou UniversityYue Bei People's HospitalQujing Normal UniversityHarbin Medical UniversityThird Affiliated Hospital of Harbin Medical UniversitySecond Affiliated Hospital of Anhui Medical UniversityBengbu Medical CollegeFirst Affiliated Hospital of Bengbu Medical CollegeYuncheng UniversityLiuzhou General HospitalNanyang Medical CollegeFirst Affiliated Hospital of Zhengzhou UniversityGuangzhou Medical UniversityNanchong Central HospitalSun Yat-sen UniversitySun Yat-sen Memorial HospitalGanzhou People's HospitalCentral South UniversityThird Xiangya HospitalFourth People’s Hospital of JinanJinan City People's HospitalShandong First Medical UniversityChengdu Medical CollegeChengdu UniversityFirst Affiliated Hospital of Chengdu Medical CollegeFuyang City People's HospitalFirst Affiliated Hospital of Xiamen UniversityShanxi Fenyang HospitalBaotou Central HospitalKunming Medical UniversityFirst Affiliated Hospital of Henan University of Science and TechnologyWuhan UniversityRenmin Hospital of Wuhan UniversityShenyang Ninth People's HospitalThe Central Hospital of Enshi Tujia and Miao Autonomous PrefectureTaizhou Central HospitalWuxi No.2 People's HospitalWuxi People's HospitalNanyang Institute of TechnologySuizhou Central HospitalGansu Provincial HospitalHuizhou Central People's HospitalJiangmen Central HospitalThe Central Hospital of ShaoyangCentral Hospital of WuhanChangzhi Medical College Peace HospitalAffiliated Zhongshan Hospital of Dalian UniversityJilin Medical UniversityDaqing City People's HospitalXi'an Chest HospitalXian Yang Central HospitalMedical Center HospitalFirst Affiliated Hospital of University of South ChinaUniversity of South ChinaQingdao UniversityQingdao Municipal HospitalQiqihar Medical UniversityHanzhong People's HospitalFoshan Hospital of TCMXiamen Chang Gung HospitalHuaian First People’s HospitalNanjing Medical UniversityAmerican Petroleum InstituteAffiliated Hospital of Shaanxi University of Chinese MedicineShaanxi University of Chinese MedicineChina Pharmaceutical UniversityNanjing Normal University

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Lung Cancer Treatments and MutationsFibroblast Growth Factor ResearchInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Lire en accès ouvert Consulter la publication primaire Ouvrir le DOI

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.